Conjunctivitis, Bacterial Clinical Trials

The Primary Objective if this study is to evaluate the efficacy of SHP640 based on clinical resolution (Defined as absence of bulbar conjunctival injection and ocular conjunctival discharge) compared with placebo in the treatment of subject with Bacterial Conjunctivitis in the study at Visit 3(Day5).

You or your child may be experiencing Bacterial Conjunctivitis, commonly known as Pink eye. To see if you or your child may qualify to take part in a clinical research study of an investigational eye drop compared to placebo (an inactive substance) - contact a participating local physician. Pink Eye ...

There are 48 patients will divided into group A and group B randomly . subjects of Group A will given the first test drug, elution after the control drug; Subjects of Group B will given the first control drug, elution given to the test drug.

Keratitis is a rare destructive cause of blindness. It typically affects young and healthy individuals, is excruciatingly painful, and difficult to treat. With 60% of cases mis-diagnosed at presentation, acanthamoeba keratitis carries a far worse visual prognosis compared to other cornea infections. Exposure to hot tubs is a widely accepted ...

Phase I clinical trial, to evaluate the safety and tolerability of the ophthalmic solution PRO-174 versus Sophixn Ofteno, elaborated by Laboratorios Sophia, S.A. of C.V. on the ocular surface of ophthalmologically and clinically healthy subjects. Goals Methodology Phase I clinical trial, controlled, of parallel groups, double blind, randomized, exploratory. Number ...

The study subjects will be recruited from various research centers in western and central Mexico. Each research center has a monitoring plan specified according to the recruitment capabilities of the same, which must be at least once a month, where the queries of your data entered into the electronic case ...